Comparison of a soluble co-formulation of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in type 2 diabetes: A randomised trial (European Journal of Endocrinology 167 (287-294))

1. Niskanen, L.
2. Leiter, L.A.
3. Franek, E.
4. Weng, J.
5. Damci, T.
6. Muñoz-Torres, M.
7. Donnet, J.-P.
8. Endahl, L.
9. Skjøth, T.V.
10. Vaag, A.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1530/EJE-12-0293E GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus